36 related articles for article (PubMed ID: 24424889)
1. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
[TBL] [Abstract][Full Text] [Related]
2. Zerumbone suppresses IKKα, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells.
Weng HY; Hsu MJ; Wang CC; Chen BC; Hong CY; Chen MC; Chiu WT; Lin CH
J Biomed Sci; 2012 Oct; 19(1):86. PubMed ID: 23035900
[TBL] [Abstract][Full Text] [Related]
3. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.
Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M
Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
[TBL] [Abstract][Full Text] [Related]
5. Hispidin Increases Cell Apoptosis and Ferroptosis in Prostate Cancer Cells Through Phosphatidylinositol-3-Kinase and Mitogen-activated Protein Kinase Signaling Pathway.
Wang YJ; Hao YY; Lee DH; Guo XY; Sun HN; Kwon T
Anticancer Res; 2024 Jun; 44(6):2533-2544. PubMed ID: 38821596
[TBL] [Abstract][Full Text] [Related]
6. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy.
Zhang Z; Li M; Wang H; Agrawal S; Zhang R
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11636-41. PubMed ID: 13130078
[TBL] [Abstract][Full Text] [Related]
7. Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells.
Thakur G; Prakash G; Murthy V; Sable N; Menon S; Alrokayan SH; Khan HA; Murugaiah V; Bakshi G; Kishore U; Madan T
Front Oncol; 2019; 9():565. PubMed ID: 31355132
[TBL] [Abstract][Full Text] [Related]
8. Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract.
Garcia GE; Nicole A; Bhaskaran S; Gupta A; Kyprianou N; Kumar AP
Neoplasia; 2006 Jun; 8(6):523-33. PubMed ID: 16820098
[TBL] [Abstract][Full Text] [Related]
9. Eprinomectin, a novel semi-synthetic macrocylic lactone is cytotoxic to PC3 metastatic prostate cancer cells via inducing apoptosis.
Samy ALPA; Bakthavachalam V; Vudutha M; Vinjamuri S; Chinnapaka S; Munirathinam G
Toxicol Appl Pharmacol; 2020 Aug; 401():115071. PubMed ID: 32454055
[TBL] [Abstract][Full Text] [Related]
10. The anti-cancerous activity of recombinant trichosanthin on prostate cancer cell PC3.
Li J; Li H; Zhang Z; Wang N; Zhang Y
Biol Res; 2016 Mar; 49():21. PubMed ID: 27015938
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumoral role of Hesperidin and Aprepitant on prostate cancer cells through redox modifications.
Akbari S; Assaran Darban R; Javid H; Esparham A; Hashemy SI
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3559-3567. PubMed ID: 37249616
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycolysis and SIRT1/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells.
Park Y; Lee HJ; Sim DY; Park JE; Ahn CH; Park SY; Lee YC; Shim BS; Kim B; Kim SH
Phytother Res; 2024 Mar; 38(3):1235-1244. PubMed ID: 38176954
[TBL] [Abstract][Full Text] [Related]
13. Drastic Synergy of Lovastatin and
Yao CJ; Chang CL; Hu MH; Liao CH; Lai GM; Chiou TJ; Ho HL; Kuo HC; Yang YY; Whang-Peng J; Chuang SE
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960146
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 4-hydroxynonenal-induced p53-mediated apoptosis in prostate cancer cells LNCaP and DU145.
Cao ZG; Xu X; Xue YM; Zhao SL
Contemp Oncol (Pozn); 2014; 18(1):22-8. PubMed ID: 24876817
[TBL] [Abstract][Full Text] [Related]
15. Long-term expression changes of immune-related genes in prostate cancer after radiotherapy.
Eke I; Aryankalayil MJ; Bylicky MA; Sandfort V; Vanpouille-Box C; Nandagopal S; Graves EE; Giaccia AJ; Coleman CN
Cancer Immunol Immunother; 2022 Apr; 71(4):839-850. PubMed ID: 34435232
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status.
Li J; Gu T; Hu S; Jin B
PLoS One; 2023; 18(10):e0286758. PubMed ID: 37796968
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of alkylphospholipid edelfosine in prostate cancer models and endoplasmic reticulum targeting.
Dakir EH; Gajate C; Mollinedo F
Biomed Pharmacother; 2023 Nov; 167():115436. PubMed ID: 37683591
[TBL] [Abstract][Full Text] [Related]
18. Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells.
Rana Z; Tyndall JDA; Hanif M; Hartinger CG; Rosengren RJ
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33572730
[TBL] [Abstract][Full Text] [Related]
19. [Effects of dexmedetomidine on the proliferation, invasiveness and tumorigenesis of human prostate cancer PC3 cells and its action mechanism].
Zhang XQ; Tan HB; Fan YH
Zhonghua Nan Ke Xue; 2022 Apr; 28(4):301-306. PubMed ID: 37477450
[TBL] [Abstract][Full Text] [Related]
20. ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
Sugiura R; Satoh R; Takasaki T
Cells; 2021 Sep; 10(10):. PubMed ID: 34685488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
